The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics

• Status: Recruiting
• Trial end date: 2022-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to determine the effect of the treatment of polycystic ovary syndrome with two different oral contraceptives that contain cyproterone acetate and drospirenone

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Inonu University
• Treatments: Cyproterone acetate, ethinyl estradiol drug combination

Criteria

Inclusion Criteria:

• Patients who are diagnosed with polycystic ovary syndrome according to Rotterdam criteria and who do not have any additional chronic systemic disease

Exclusion Criteria:

• The presence of any diseases that cause hormonal disorders and any chronic systemic diseases, the patients who are already under any treatment for polycystic ovary syndrome